The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Blood Levels of Homocysteine and Increased Risks of Cardiovascular Disease: Causal or Casual?
Open accessAbstract
BACKGROUND: Accumulating data from epidemiological studies suggest that individuals with elevated blood levels of homocysteine have increased risks of cardiovascular disease. We reviewed the currently available evidence of an association between homocysteine and cardiovascular disease and examined whether the strength of the evidence varies according to study design. METHODS: We used a computerized MEDLINE literature search, 1966 through September 1998, to identify all epidemiological studies that examined the relationship of homocysteine level with risks of coronary heart or cerebrovascular disease. Two measures of plasma homocysteine level and its association with risk of cardiovascular disease were extracted: mean homocysteine level in cases and controls, and relative risk of cardiovascular disease for elevated homocysteine level. RESULTS: A total of 43 studies were reviewed. Most crosssectional and case-control studies indicated higher mean homocysteine levels (either fasting or after methionine load) and/or a greater frequency of elevated homocysteine level in persons with cardiovascular disease as compared with persons without cardiovascular disease. Results of most prospective studies, however, indicated smaller or no association. The few prospective studies that reported a positive association between homocysteine level and risks of cardiovascular disease included patients with preexisting vascular disease. CONCLUSIONS: In contrast to cross-sectional and case-control studies, results of prospective studies indicated less or no predictive ability for plasma homocysteine in cardiovascular disease. Instead, elevated homocysteine level may be an acute-phase reactant that is predominantly a marker of atherogenesis, or a consequence of other factors more closely linked to risks of cardiovascular disease. Randomized trials are necessary to test reliably whether lowering homocysteine levels will decrease risks of cardiovascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Methods in Cancer Research
Breslow, N. E. (1980) · Cited by 7,332
Statistical methods in cancer research. Volume I - The analysis of case-control studies.
Breslow, N. E., & Day, N. E. (1980) · PubMed · Cited by 4,988
Boushey, C. J. (1995) · JAMA · doi:10.1001/jama.1995.03530130055028 · Cited by 3,584
ON ESTIMATING THE RELATION BETWEEN BLOOD GROUP AND DISEASE
WOOLF, B. (1955) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1955.tb01348.x · Cited by 2,723
Hennekens, C. H., Buring, J. E., & Mayrent, S. L. (1987) · Medical Entomology and Zoology · Cited by 2,319
Self-citationHyperhomocysteinemia: An Independent Risk Factor for Vascular Disease
Clarke, R., Daly, L., Robinson, K., Naughten, E., Cahalane, S., Fowler, B., & Graham, I. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104253241701 · Cited by 2,161
Vitamin Status and Intake as Primary Determinants of Homocysteinemia in an Elderly Population
Selhub, J. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510220049033 · Cited by 1,972
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-2-316_4 · Cited by 1,926
Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis.
Ks, M. (1969) · PubMed Central · Cited by 1,803
Plasma Homocysteine Levels and Mortality in Patients with Coronary Artery Disease
Nygård, O., Nordrehaug, J. E., Refsum, H., Ueland, P. M., Farstad, M., & Vollset, S. E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707243370403 · Cited by 1,756
Plasma Homocysteine as a Risk Factor for Vascular Disease: The European Concerted Action Project
Graham, I. M. (1997) · JAMA · doi:10.1001/jama.1997.03540460039030 · Cited by 1,738
Statistical methods in cancer research. Vol. 1. The analysis of case-control studies
(1983) · Food and Chemical Toxicology · doi:10.1016/0278-6915(83)90281-8 · Cited by 1,716
A Prospective Study of Plasma Homocyst(e)ine and Risk of Myocardial Infarction in US Physicians
Stampfer, M. J. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03490070059042 · Cited by 1,709
Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis
Selhub, J., Jacques, P. F., Bostom, A. G., D'Agostino, R. B., Wilson, P. W. F., Belanger, A. J., O'Leary, D. H., Wolf, P. A., Schaefer, E. J., & Rosenberg, I. H. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320502 · Cited by 1,216
Relation of C-Reactive Protein and Coronary Heart Disease in the MRFIT Nested Case-Control Study
for the MRFIT Research Group, Kuller, L. H., Tracy, R. P., Shaten, J., & Meilahn, E. N. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008963 · Cited by 1,097
Total Plasma Homocysteine and Cardiovascular Risk Profile: The Hordaland Homocysteine Study
Nygård, O., Vollset, S. E., Refsum, H., Stensvold, I., Tverdal, A., Nordrehaug, J. E., Ueland, P. M., & Kvåle, G. (1995) · JAMA · doi:10.1001/jama.1995.03530190040032 · Cited by 1,042
Harker, L. A., Ross, R., Slichter, S. J., & Scott, C. R. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108520 · Cited by 933
Perry, I. J., Morris, R. W., Ebrahim, S. B., Shaper, A. G., Refsum, H., & Ueland, P. M. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92407-8 · Cited by 883
Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine.
Starkebaum, G., & Harlan, J. M. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112442 · Cited by 822
Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis.
Tsai, J. C., Perrella, M. A., Yoshizumi, M., Hsieh, C. M., Haber, E., Schlegel, R., & Lee, M. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6369 · Cited by 798
Boushey, C. J. (1995) · JAMA · doi:10.1001/jama.274.13.1049 · Cited by 767
Hyperhomocyst(e)inemia as a Risk Factor for Occlusive Vascular Disease
Kang, S. S., Wong, P. W. K., & Malinow, M. R. (1992) · Annual Review of Nutrition · doi:10.1146/annurev.nu.12.070192.001431 · Cited by 762
Heterozygosity for Homocystinuria in Premature Peripheral and Cerebral Occlusive Arterial Disease
Boers, G. H. J., Smals, A. G. H., Trijbels, F. J. M., Fowler, B., Bakkeren, J. A. J. M., Schoonderwaldt, H. C., Kleijer, W. J., & Kloppenborg, P. W. C. (1985) · New England Journal of Medicine · doi:10.1056/nejm198509193131201 · Cited by 732
Kluijtmans, L. A. J., van den Heuvel, L. P., Boers, G. H. J., Frosst, P. D., Stevens, E. M., van Oost, B. A., den Heijer, M., Trijbels, F. J. M., Rozen, R. R., & Blom, H. J. (1996) · PubMed Central · Cited by 653
Serum Total Homocysteine and Coronary Heart Disease
ARNESEN, E., REFSUM, H., BØNAA, K. H., UELAND, P. M., FØRDE, O. H., & NORDREHAUG, J. E. (1995) · International Journal of Epidemiology · doi:10.1093/ije/24.4.704 · Cited by 651
Folsom, A. R., Nieto, F. J., McGovern, P. G., Tsai, M. Y., Malinow, M. R., Eckfeldt, J. H., Hess, D. L., & Davis, C. E. (1998) · Circulation · doi:10.1161/01.cir.98.3.204 · Cited by 603
Ueland, P. M., & Refsum, H. (1989) · PubMed · Cited by 595
The pathogenesis of coronary artery disease. A possible role for methionine metabolism.
Wilcken, D. E., & Wilcken, B. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108350 · Cited by 529
Alfthan, G., Pekkanen, J., Jauhiainen, M., Pitkäniemi, J., Karvonen, M., Tuomilehto, J., Salonen, J. T., & Ehnholm, C. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90078-7 · Cited by 527
Homocysteine and coronary atherosclerosis
Mayer, E. L., Jacobsen, D. W., & Robinson, K. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00508-0 · Cited by 519
Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease.
Malinow, M. R., Kang, S. S., Taylor, L. M., Wong, P. W., Coull, B., Inahara, T., Mukerjee, D., Sexton, G., & Upson, B. (1989) · Circulation · doi:10.1161/01.cir.79.6.1180 · Cited by 501
Homocysteine-induced endothelial cell injury in vitro: A model for the study of vascular injury
Wall, R. T., Harlan, J. M., Harker, L. A., & Striker, G. E. (1980) · Thrombosis Research · doi:10.1016/0049-3848(80)90175-9 · Cited by 483
Verhoef, P., Stampfer, M. J., Buring, J. F., Gaziano, J. M., Allen, R. H., Stabler, S. P., Reynolds, R. D., Kok, F. J., Hennekens, C. H., & Willett, W. C. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008828 · Cited by 480
Self-citationVitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia
Ubbink, J., Vermaak, W., van der Merwe, A., & Becker, P. (1993) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/57.1.47 · Cited by 461
Heinecke, J. W., Rosen, H., Suzuki, L. A., & Chait, A. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61082-8 · Cited by 460
Bostom, A. G., & Lathrop, L. (1997) · Kidney International · doi:10.1038/ki.1997.298 · Cited by 456
Malinow, M. R., Nieto, F. J., Szklo, M., Chambless, L. E., & Bond, G. (1993) · Circulation · doi:10.1161/01.cir.87.4.1107 · Cited by 451
Homocysteinemia due to folate deficiency
Kang, S.-S., Wong, P. W. K., & Norusis, M. (1987) · Metabolism · doi:10.1016/0026-0495(87)90043-6 · Cited by 421
Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus
Petri, M., Roubenoff, R., Dallal, G. E., Nadeau, M. R., Selhub, J., & Rosenberg, I. H. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03032-2 · Cited by 419
Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project
Graham, I. M. (1997) · JAMA · doi:10.1001/jama.277.22.1775 · Cited by 405
Rodgers, G., & Conn, M. (1990) · Blood · doi:10.1182/blood.v75.4.895.895 · Cited by 398
Robinson, K., Mayer, E. L., Miller, D. P., Green, R., van Lente, F., Gupta, A., Kottke-Marchant, K., Savon, S. R., Selhub, J., Nissen, S. E., et al. (1995) · Circulation · doi:10.1161/01.cir.92.10.2825 · Cited by 390
Brattström, L., Israelsson, B., Norrving, B., Bergqvist, D., Thörne, J., Hultberg, B., & Hamfelt, A. (1990) · Atherosclerosis · doi:10.1016/0021-9150(90)90058-q · Cited by 389
Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator.
Rodgers, G. M., & Kane, W. H. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112519 · Cited by 384
Pancharuniti, N., Lewis, C., Sauberlich, H., Perkins, L., Go, R., Alvarez, J., Macaluso, M., Acton, R., Copeland, R., Cousins, A., et al. (1994) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/59.4.940 · Cited by 380
A prospective study of plasma homocyst(e)ine and risk of ischemic stroke.
Verhoef, P., Hennekens, C. H., Malinow, M. R., Kok, F. J., Willett, W. C., & Stampfer, M. J. (1994) · Stroke · doi:10.1161/01.str.25.10.1924 · Cited by 379
Self-citationWald, N. J., Watt, H. C., Law, M. R., Weir, D. G., McPartlin, J., & Scott, J. M. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.8.862 · Cited by 369
Folic acid—an innocuous means to reduce plasma homocysteine
Brattström, L. E., Israelsson, B., Jeppsson, J.-O., & Hultberg, B. L. (1988) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365518809167487 · Cited by 363
Vitamin Requirements for the Treatment of Hyperhomocysteinemia in Humans
Ubbink, J. B., Hayward Vermaak, W., Merwe, A. V. D., Becker, P. J., Delport, R., & Potgieter, H. C. (1994) · The Journal of Nutrition · doi:10.1093/jn/124.10.1927 · Cited by 357
Homocyst(e)ine and Risk of Cardiovascular Disease in the Multiple Risk Factor Intervention Trial
Evans, R. W., Shaten, B. J., Hempel, J. D., Cutler, J. A., & Kuller, L. H. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.10.1947 · Cited by 342
Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke.
Coull, B. M., Malinow, M. R., Beamer, N., Sexton, G., Nordt, F., & de Garmo, P. (1990) · Stroke · doi:10.1161/01.str.21.4.572 · Cited by 308
Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease.
Kang, S. S., Wong, P. W., Cook, H. Y., Norusis, M., & Messer, J. V. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112461 · Cited by 302
Plasma homocyst(e)ine levels in men with premature coronary artery disease
Genest, J. J., McNamara, J. R., Salem, D. N., Wilson, P. W. F., Schaefer, E. J., & Malinow, M. R. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)90542-w · Cited by 296
Moderate homocysteinemia--a possible risk factor for arteriosclerotic cerebrovascular disease.
Brattstrom, L. E., Hardebo, J. E., & Hultberg, B. L. (1984) · Stroke · doi:10.1161/01.str.15.6.1012 · Cited by 282
A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians.
Chasan-Taber, L., Selhub, J., Rosenberg, I. H., Malinow, M. R., Terry, P., Tishler, P. V., Willett, W., Hennekens, C. H., & Stampfer, M. J. (1996) · Journal of the American College of Nutrition · doi:10.1080/07315724.1996.10718578 · Cited by 273
Self-citationBRATTSTRÖM, L., LINDGREN, A., ISRAELSSON, B., MALINOW, M. R., NORRVING, B., UPSON, B., & HAMFELT, A. (1992) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1992.tb01829.x · Cited by 257
Homocystinuria — The Effects of Betaine in the Treatment of Patients Not Responsive to Pyridoxine
Wilcken, D. E. L., Wilcken, B., Dudman, N. P. B., & Tyrrell, P. A. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308253090802 · Cited by 243
Homocysteine and Risk of Premature Coronary Heart Disease: Evidence for a Common Gene Mutation
Gallagher, P. M., Meleady, R., Shields, D. C., Tan, K. S., McMaster, D., Rozen, R., Evans, A., Graham, I. M., & Whitehead, A. S. (1996) · Circulation · doi:10.1161/01.cir.94.9.2154 · Cited by 236
Plasma Total Homocysteine, B Vitamins, and Risk of Coronary Atherosclerosis
Verhoef, P., Kok, F. J., Kruyssen, D. A. C. M., Schouten, E. G., Witteman, J. C. M., Grobbee, D. E., Ueland, P. M., & Refsum, H. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.5.989 · Cited by 234
Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study
Nygard, O. K. (1995) · JAMA · doi:10.1001/jama.274.19.1526 · Cited by 234
Parthasarathy, S. (1987) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(87)90139-1 · Cited by 233
The effect of reduced glomerular filtration rate on plasma total homocysteine concentration
Arnadottir, M., Hultberg, B., Nilsson-Ehle, P., & Thysell, H. (1996) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365519609088586 · Cited by 233
Schwartz, S. M., Siscovick, D. S., Malinow, M. R., Rosendaal, F. R., Beverly, R. K., Hess, D. L., Psaty, B. M., Longstreth, W. T., Koepsell, T. D., Raghunathan, T. E., et al. (1997) · Circulation · doi:10.1161/01.cir.96.2.412 · Cited by 231
Brattström, L., Israelsson, B., Lindgärde, F., & Hultberg, B. (1988) · Metabolism · doi:10.1016/s0026-0495(98)90014-2 · Cited by 221
Plasma Homocysteine in the Acute and Convalescent Phases After Stroke
Lindgren, A., Brattström, L., Norrving, B., Hultberg, B., Andersson, A., & Johansson, B. B. (1995) · Stroke · doi:10.1161/01.str.26.5.795 · Cited by 216
Plasma homocysteine in acute myocardial infarction: homocysteine‐lowering effect of folic acid
LANDGREN, F., ISRAELSSON, B., LINDGREN, A., HULTBERG, B., ANDERSSON, A., & Brattström, L. (1995) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1995.tb01190.x · Cited by 203
Dudman, N. P., Wilcken, D. E., Wang, J., Lynch, J. F., Macey, D., & Lundberg, P. (1993) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.13.9.1253 · Cited by 203
Kuller, L. H., Eichner, J. E., Orchard, T. J., Grandits, G. A., McCallum, L., Tracy, R. P., & for the Multiple Risk Factor Intervention Trial Research Group (1991) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116030 · Cited by 199
ARAKI, A., SAKO, Y., FUKUSHIMA, Y., MATSUMOTO, M., ASADA, T., & KITA, T. (1989) · Atherosclerosis · doi:10.1016/0021-9150(89)90118-4 · Cited by 192
Dalery, K., Lussier-Cacan, S., Selhub, J., Davignon, J., Latour, Y., & Genest, J. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80739-5 · Cited by 191
Homocysteine and myocardial infarction
Israelsson, B., Brattström, L. E., & Hultberg, B. L. (1988) · Atherosclerosis · doi:10.1016/0021-9150(88)90147-5 · Cited by 191
Plasma Homocysteine and Cardiovascular Disease
Ueland, P. M., & Refsum, H. (2000) · Cited by 186
Plasma homocyst(e)ine as a risk factor for early familial coronary artery disease
Wu, L. L., Wu, J., Hunt, S. C., James, B. C., Vincent, G. M., Williams, R. R., & Hopkins, P. N. (1994) · Clinical Chemistry · doi:10.1093/clinchem/40.4.552 · Cited by 179
Treatment of mild hyperhomocysteinemia in vascular disease patients.
Franken, D. G., Boers, G. H., Blom, H. J., Trijbels, F. J., & Kloppenborg, P. W. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.3.465 · Cited by 178
Thermolabile methylenetetrahydrofolate reductase in patients with coronary artery disease
Kang, S.-S., Wong, P. W. K., Zhou, J., Sora, J., Lessick, M., Ruggie, N., & Grcevich, G. (1988) · Metabolism · doi:10.1016/0026-0495(88)90076-5 · Cited by 171
Norlund, L., GRUBB, A. O., Fex, G. A., Leksell, H., Nilsson, J.-E., von Schenck, H., & Hultberg, B. L. (1998) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1998.032 · Cited by 156
Preventing Coronary Heart Disease
Omenn, G. S., Beresford, S. A. A., & Motulsky, A. G. (1998) · Circulation · doi:10.1161/01.cir.97.5.421 · Cited by 149
Jacob, R. A., Wu, M.-M., Henning, S. M., & Swendseid, M. E. (1994) · Journal of Nutrition · doi:10.1093/jn/124.7.1072 · Cited by 141
Methionine intolerance: A possible risk factor for coronary artery disease
Murphy-Chutorian, D. R., Wexman, M. P., Grieco, A. J., Heininger, J. A., Glassman, E., Gaull, G. E., Ng, S. K. C., Feit, F., Wexman, K., & Fox, A. C. (1985) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(85)80473-3 · Cited by 141
von Eckardstein, A., Malinow, M. R., Upson, B. M., Heinrich, J., Schulte, H., Schönfeld, R., Köhler, E., & Assmann, G. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.3.460 · Cited by 140
Endothelial cell dysfunction in homocystinuria
de Groot, P. G., Willems, C. E. D., Boers, G. H. J., et al. (1983) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1983.tb00121.x · Cited by 138
Inherited Defects Of Vitamin B12 Metabolism
Cooper, B. A., & Rosenblatt, D. S. (1987) · Annual Review of Nutrition · doi:10.1146/annurev.nu.07.070187.001451 · Cited by 132
Serial measures of plasma homocyst(e)ine after acute myocardial infarction
Egerton, W., Silberberg, J. S., Crooks, R., Ray, C. D., Xie, L., & Dudman, N. P. B. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89213-2 · Cited by 125
A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women
Manson, J. E., Gaziano, J. M., Spelsberg, A., Ridker, P. M., Cook, N. R., Buring, J. E., Willett, W. C., & Hennekens, C. H. (1995) · Annals of Epidemiology · doi:10.1016/1047-2797(94)00091-7 · Cited by 119
Self-citationUbbink, J., Vermaak, W. J. H., Bennett, J. M., Becker, P., Staden, D. A. V., & Bissbort, S. (1991) · Journal of Molecular Medicine · doi:10.1007/bf01649290 · Cited by 118
Homocysteine, Vitamins, and Cardiovascular Disease
Kuller, L. H., & Evans, R. G. (1998) · Circulation · doi:10.1161/01.cir.98.3.196 · Cited by 115
van den Berg, M., Franken, D. G., Boers, G. H. J., Blom, H. J., Jakobs, C., Stehouwer, C. D. A., & Rauwerda, H. (1994) · Journal of Vascular Surgery · doi:10.1016/0741-5214(94)90230-5 · Cited by 115
Effect of Homocysteine and Homocystine on Platelet and Vascular Arachidonic Acid Metabolism
Graeber, J. E., Slott, J. H., Ulane, R. E., Schulman, J. D., & Stuart, M. J. (1982) · Pediatric Research · doi:10.1203/00006450-198206000-00018 · Cited by 112
Controlled Dietary Folate Affects Folate Status in Nonpregnant Women
O'Keefe, C. A., Bailey, L. B., Thomas, E. A., Hofler, S. A., Davis, B. A., Cerda, J. J., & Gregory, J. F. (1995) · Journal of Nutrition · doi:10.1093/jn/125.10.2717 · Cited by 110
Ubbink, J., Becker, P., Vermaak, W. J. H., & Delport, R. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.7.1033 · Cited by 108
Folic acid responsive postmenopausal homocysteinemia
Brattström, L. E., Hultberg, B. L., & Hardebo, J. E. (1985) · Metabolism · doi:10.1016/0026-0495(85)90082-4 · Cited by 106
Plasma Total Homocysteine and Risk of Angina Pectoris With Subsequent Coronary Artery Bypass Surgery
Verhoef, P., Hennekens, C. H., Allen, R. H., Stabler, S. P., Willett, W. C., & Stampfer, M. J. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00874-0 · Cited by 96
Self-citationHyperhomocysteinemia and the response to vitamin supplementation
Ubbink, J., van der Merwe, A. M., Vermaak, W. J. H., & Delport, R. (1993) · Journal of Molecular Medicine · doi:10.1007/bf00180030 · Cited by 86
Plasma homocysteine levels and mortality in patients with coronary artery disease
(1998) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1016/s1053-0770(98)90076-3 · Cited by 82
Plasma Homocyst(e)ine: A Risk Factor for Arterial Occlusive Diseases
MALINOW, M. R. (1996) · Journal of Nutrition · doi:10.1093/jn/126.suppl_4.1238s · Cited by 73
Plasma homocysteine in relation to serum cobalamin and blood folate in a psychogeriatric population
Nilsson, K. H., Gustafson, L., Fäldt, R., Andersson, A. D. R., & Hultberg, B. L. (1994) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1994.tb01111.x · Cited by 71
Disordered methionine/homocysteine metabolism in premature vascular disease
Taylor, L. M. (1994) · Journal of Vascular Surgery · doi:10.1016/0741-5214(94)90258-5 · Cited by 61
Israelsson, B., Brattström, L. E., & Refsum, H. (1993) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365519309092541 · Cited by 60
Prospective Studies of Homocysteine and Cardiovascular Disease
Verhoef, P., & Stampfer, M. J. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1995.tb01478.x · Cited by 58
Franken, D. G., Boers, G. H. J., Blom, H. J., & Trijbels, J. M. F. (1994) · Journal of Inherited Metabolic Disease · doi:10.1007/bf00735426 · Cited by 51
Prospective Studies of Homocysteine and Cardiovascular Disease
Stampfer, M. J., & Verhoef, P. (1997) · Developments in cardiovascular medicine · doi:10.1007/978-1-4615-5771-5_32 · Cited by 49
Hyperhomocysteinaemia: a risk factor for extracranial carotid artery atherosclerosis
Clarke, R., Fitzgerald, D. E., O’Brien, C., O'Farrell, C. M., Roche, G., Parker, R. A., & Graham, I. M. (1992) · Irish Journal of Medical Science (1971 -) · doi:10.1007/bf02983714 · Cited by 30
Total plasma homocysteine determination in subjects with premature cerebral vascular disease
Méreau-Richard, C., Muller, J. P., Faivre, E., Ardouin, P., & Rousseaux, J. (1991) · Clinical Chemistry · doi:10.1093/clinchem/37.1.126 · Cited by 23
Cited by
Facts and recommendations about total homocysteine determinations: an expert opinion
Refsum, H., Smith, A. D., Ueland, P. M., Nexo, E., Clarke, R., McPartlin, J., Johnston, C., Engbaek, F., Schneede, J., McPartlin, C., et al. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.021634 · Cited by 1,056
Goldstein, L. B., Adams, R., Becker, K., Furberg, C. D., Gorelick, P. B., Hademenos, G., Hill, M., Howard, G., Howard, V. J., Jacobs, B., et al. (2001) · Stroke · doi:10.1161/01.str.32.1.280 · Cited by 905
Emerging Risk Factors for Atherosclerotic Vascular Disease: A Critical Review of the Evidence
Hackam, D. G., & Anand, S. S. (2003) · JAMA · doi:10.1001/jama.290.7.932 · Cited by 550
Update on Cobalamin, Folate, and Homocysteine
Carmel, R., Green, R., Rosenblatt, D. S., & Watkins, D. (2003) · Hematology · doi:10.1182/asheducation-2003.1.62 · Cited by 391
Goldstein, L. B., Adams, R., Becker, K., Furberg, C. D., Gorelick, P. B., Hademenos, G., Hill, M., Howard, G., Howard, V. J., Jacobs, B., et al. (2001) · Circulation · doi:10.1161/01.cir.103.1.163 · Cited by 373
Metadata
- Authors
- Christen, W. G., Ajani, U. A., Glynn, R. J., & Hennekens, C. H.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2000-02-28
- Volume
- 160
- Issue
- 4
- Pages
- 422
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2099107808
- Cited by
- 304
- References
- 103
- FWCI
- 25.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.